Figure 2From: Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients Dot-plots of serum levels of nucleosomes, alkaline phosphatase (AP), alpha fetoprotein (AFP) and gamma-glutamyl-transferase (GGT) with respective medians of patients with response to therapy (○) and those with no response to therapy (●) for all time points during the first day after TACE (★ indicate significant differences).Back to article page